On October 10, mindbodygreen headlined that a diet ‘may lower’ breast cancer odds by 59%. The study compared 600 women with breast cancer in Isfahan, Iran, with 600 without. The page sells its own omega-3. The headline gives one number and no base. Its 59% is the study’s odds ratio of 0.41 for women scoring above 6 on a 0 to 10 dietary diversity score, set against the lowest group. Neither the abstracts nor the page says how common breast cancer was among these women, so 59% of what stays unknown. The study’s own range runs from 0.23 to 0.73: a drop anywhere from 27% to 77%. The tell: a percentage with no base is a feeling, not a size. The study is observational. Researchers compared 600 newly diagnosed women in Isfahan, Iran, with 600 women from the general population, using a 168-item questionnaire about the past year’s eating, answered after diagnosis. That can show a link; it cannot show the diet did the lowering. The page’s own headline says “Linked To”. The headline built for social feeds says “May Lower”. The page gives the study size in its fourth paragraph and never says Iran or case-control. Below the text sit repeated “Shop now” modules for mindbodygreen’s own omega-3 potency+ supplement, linked to its store, and a related read on omega-3 supplements. The study is about variety on the plate, not capsules. The page carries no paid-content label, and its footer says the product is not intended to prevent any disease. Neither abstract names a funder. A reader arrives with a fear about cancer and finds a cart.
